HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CPAC

Cementos Pacasmayo S.A.A. (NYSE)

Basic Materials — Building Materials

Cementos Pacasmayo S.A.A. produces, distributes, and sells cement and cement-related materials in Peru. It operates in three segments: Cement, Concrete, Mortar, Pavement and Precast; Quicklime; and Sales of Construction Supplies. The company offers cement and concrete products for use in residential and commercial construction, and civil engineering; ready-mix concrete for use in construction sites; concrete precast, such as paving units or paver stones for pedestrian walkways, as well as other bricks for partition walls and concrete precast for structural and non-structural uses; and cement-based products. It also produces and distributes quicklime for use in steel, food, fishing, and chemical industries. In addition, the company sells and distributes other construction materials manufactured by third parties, such as steel rebar, wires, nails, corrugated iron, electric conductors, and plastic tubes and accessories. It offers its products directly to other retailers, private construction companies, and through a network of independent retailers and hardware stores. Cementos Pacasmayo S.A.A. was incorporated in 1949 and is headquartered in Lima, Peru. Cementos Pacasmayo S.A.A. is a subsidiary of Inversiones ASPI S.A.

Buy 2.3 / 5 3 analysts
$11.82
$-0.14 (-1.17%)
Target: $11.93 (1.0%)
Sign in to add CPAC to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$1.01B
P/E Ratio (TTM)19.06
Forward P/E76.75
EPS (TTM)$0.62
Dividend Yield5.15%
Profit Margin8.44%
Revenue Growth11.30%
ROE14.45%
Debt/Equity113.24
Recommendation Buy 2.3
Analyst Target$11.93
Analysts3
Indexes NYSE

Technical Indicators

RSI (14)67.2
Beta0.13
SMA 20-
SMA 40-
52-Week High$12.70
52-Week Low$5.66
50-Day Avg$10.90
200-Day Avg$9.50
Avg Volume60.6K
Volume15.4K

Performance Analysis

BULLISH

CPAC shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 87% of its 52-week range.
+ RSI at 67.2 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 11.3% year-over-year.
+ Wall Street consensus is "Buy" from 3 analysts.
+ Average analyst target of $11.93 implies 1.0% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:04 UTC

Back to Screener Export Report